Jundishapur Journal of Microbiology

Published by: Kowsar

Design, Construction and Cloning of Truncated ORF2 and tPAsp-PADRE-Truncated ORF2 Gene Cassette From Hepatitis E Virus in the pVAX1 Expression Vector

Fatemeh Farshadpour 1 , 2 , Manoochehr Makvandi 2 and Reza Taherkhani 1 , 3 , *
Authors Information
1 Department of Microbiology and Parasitology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, IR Iran
2 Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, IR Iran
Article information
  • Jundishapur Journal of Microbiology: December 01, 2015, 8 (12); e26035
  • Published Online: December 13, 2015
  • Article Type: Research Article
  • Received: December 18, 2014
  • Revised: September 4, 2015
  • Accepted: September 20, 2015
  • DOI: 10.5812/jjm.26035

To Cite: Farshadpour F, Makvandi M, Taherkhani R. Design, Construction and Cloning of Truncated ORF2 and tPAsp-PADRE-Truncated ORF2 Gene Cassette From Hepatitis E Virus in the pVAX1 Expression Vector, Jundishapur J Microbiol. 2015 ; 8(12):e26035. doi: 10.5812/jjm.26035.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Emerson SU, Purcell RH. Fields Virology. 2013; : 2242-58
  • 2. Farshadpour F, Taherkhani R, Makvandi M. Prevalence of Hepatitis E Virus among Adults in South-West of Iran. Hepat Res Treat. 2015; : 759589[DOI][PubMed]
  • 3. Boccia D, Guthmann JP, Klovstad H, Hamid N, Tatay M, Ciglenecki I, et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis. 2006; 42(12): 1679-84[DOI][PubMed]
  • 4. Hamid SS, Atiq M, Shehzad F, Yasmeen A, Nissa T, Salam A, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology. 2002; 36(2): 474-8[DOI][PubMed]
  • 5. Taherkhani R, Farshadpour F. A new strategy for development of hepatitis E vaccine: Epitope-based vaccines. Pathogen Infect Dis. 2015; 1[DOI]
  • 6. Emerson SU, Purcell RH. Recombinant vaccines for hepatitis E. Trends Mol Med. 2001; 7(10): 462-6[DOI]
  • 7. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome. Virology. 1991; 185(1): 120-31[PubMed]
  • 8. Zhou YH, Purcell RH, Emerson SU. A truncated ORF2 protein contains the most immunogenic site on ORF2: Antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Vaccine. 2005; 23(24): 3157-65[DOI][PubMed]
  • 9. Emerson SU, Clemente-Casares P, Moiduddin N, Arankalle VA, Torian U, Purcell RH. Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. J Gen Virol. 2006; 87: 697-704[DOI][PubMed]
  • 10. Taherkhani R, Makvandi M, Farshadpour F. Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virus. Ann Lab Med. 2014; 34(2): 118-26[DOI][PubMed]
  • 11. Taherkhani R, Farshadpour F, Makvandi M, Rajabi Memari H, Samarbafzadeh AR, Sharifi N, et al. Cytokine profiles and cell proliferation responses to truncated ORF2 protein in Iranian patients recovered from hepatitis E infection. J Trop Med. 2015; 2015(15): 523560[DOI][PubMed]
  • 12. Li TC, Takeda N, Miyamura T, Matsuura Y, Wang JC, Engvall H, et al. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol. 2005; 79(20): 12999-3006[DOI][PubMed]
  • 13. Taherkhani R, Farshadpour F, Makvandi M. Design and production of a multiepitope construct derived from hepatitis E virus capsid protein. J Med Virol. 2015; 87(7): 1225-34[DOI][PubMed]
  • 14. He J, Hoffman SL, Hayes CG. DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine. 1997; 15(4): 357-62[PubMed]
  • 15. Kamili S. Toward the development of a hepatitis E vaccine. Virus Res. 2011; 161(1): 93-100[DOI][PubMed]
  • 16. Wang L, Zhuang H. Hepatitis E: An overview and recent advances in vaccine research. World J Gastroenterol. 2004; 10(15): 2157-62[PubMed]
  • 17. Navon S, Pilpel Y. The role of codon selection in regulation of translation efficiency deduced from synthetic libraries. Genome Biol. 2011; 12(2)[DOI][PubMed]
  • 18. Maertens B, Spriestersbach A, von Groll U, Roth U, Kubicek J, Gerrits M, et al. Gene optimization mechanisms: A multi-gene study reveals a high success rate of full-length human proteins expressed in Escherichia coli. Protein Sci. 2010; 19(7): 1312-26[DOI][PubMed]
  • 19. Supek F, Smuc T. On relevance of codon usage to expression of synthetic and natural genes in Escherichia coli. Genetics. 2010; 185(3): 1129-34[DOI][PubMed]
  • 20. Watts AM, Kennedy RC. DNA vaccination strategies against infectious diseases. Int J Parasitol. 1999; 29(8): 1149-63[PubMed]
  • 21. Baldwin SL, D'Souza CD, Orme IM, Liu MA, Huygen K, Denis O, et al. Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. Tuber Lung Dis. 1999; 79(4): 251-9[DOI][PubMed]
  • 22. Li Z, Howard A, Kelley C, Delogu G, Collins F, Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun. 1999; 67(9): 4780-6[PubMed]
  • 23. Alexander J, Sidney J, Southwood S, Ruppert J, Oseroff C, Maewal A, et al. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity. 1994; 1(9): 751-61[PubMed]
  • 24. Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, et al. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J Immunol. 1999; 162(7): 3915-25[PubMed]
  • 25. Farshadpour F, Taherkhani R, Makvandi M, Rajabi Memari H, Samarbafzadeh AR. Codon-Optimized Expression and Purification of Truncated ORF2 Protein of Hepatitis E Virus in Escherichia coli. Jundishapur J Microbiol. 2014; 7(7)[DOI][PubMed]
  • 26. Taherkhani R, Farshadpour F, Makvandi M, Samarbafzadeh AR. Cloning of fliC Gene From Salmonella typhimurium in the Expression Vector pVAX1 and Evaluation of its Expression in Eukaryotic Cells. Jundishapur J Microbiol. 2014; 7(11)[DOI][PubMed]
  • 27. Sharp PM, Li WH. The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res. 1987; 15(3): 1281-95[PubMed]
  • 28. Sandhu KS, Pandey S, Maiti S, Pillai B. GASCO: genetic algorithm simulation for codon optimization. In Silico Biol. 2008; 8(2): 187-92[PubMed]
  • 29. Bradel-Tretheway BG, Zhen Z, Dewhurst S. Effects of codon-optimization on protein expression by the human herpesvirus 6 and 7 U51 open reading frame. J Virol Methods. 2003; 111(2): 145-56[PubMed]
  • 30. Deml L, Bojak A, Steck S, Graf M, Wild J, Schirmbeck R, et al. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol. 2001; 75(22): 10991-1001[DOI][PubMed]
  • 31. Narum DL, Kumar S, Rogers WO, Fuhrmann SR, Liang H, Oakley M, et al. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect Immun. 2001; 69(12): 7250-3[DOI][PubMed]
  • 32. Simabuco FM, Tamura RE, Carromeu C, Farinha-Arcieri LE, Ventura AM. Gene optimization leads to robust expression of human respiratory syncytial virus nucleoprotein and phosphoprotein in human cells and induction of humoral immunity in mice. J Virol Methods. 2009; 158(1-2): 93-9[DOI][PubMed]
  • 33. Ternette N, Tippler B, Uberla K, Grunwald T. Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. Vaccine. 2007; 25(41): 7271-9[DOI][PubMed]
  • 34. Villalobos A, Welch M, Minshull J. In silico design of functional DNA constructs. Methods Mol Biol. 2012; 852: 197-213[DOI][PubMed]
  • 35. Puigbo P, Guzman E, Romeu A, Garcia-Vallve S. OPTIMIZER: A web server for optimizing the codon usage of DNA sequences. Nucleic Acids Res. 2007; 35-31[DOI][PubMed]
  • 36. Fuglsang A. Codon optimizer: a freeware tool for codon optimization. Protein Expr Purif. 2003; 31(2): 247-9[PubMed]
  • 37. Wu G, Bashir-Bello N, Freeland SJ. The Synthetic Gene Designer: a flexible web platform to explore sequence manipulation for heterologous expression. Protein Expr Purif. 2006; 47(2): 441-5[DOI][PubMed]
  • 38. Ikemura T. Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes. J Mol Biol. 1981; 146(1): 1-21[PubMed]
  • 39. Costa SM, Paes MV, Barreto DF, Pinhao AT, Barth OM, Queiroz JL, et al. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine. 2006; 24(2): 195-205[DOI][PubMed]
  • 40. Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. J Virol Methods. 2008; 154(1-2): 121-7[DOI][PubMed]
  • 41. Castellino F, Germain RN. Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol. 2006; 24: 519-40[DOI][PubMed]
  • 42. Alexander J, del Guercio MF, Frame B, Maewal A, Sette A, Nahm MH, et al. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE). Vaccine. 2004; 22(19): 2362-7[DOI][PubMed]
  • 43. Li P, Cao RB, Zheng QS, Liu JJ, Li Y, Wang EX, et al. Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime-protein boost vaccine strategy. Vet J. 2010; 183(2): 210-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments